Panbela Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$3.8M

191 transactions

Summary

Panbela Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $86KSales: $2.6M21 insiders

Date	Insider	Type	Value
2023-11-08	Joint reporting: GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC	Sell	$52K
2024-11-15	Joint reporting: SOON-SHIONG PATRICK; Nant Capital, LLC	Buy	—
2024-10-01	Simpson Jennifer K.(President and CEO)	A	$0
2024-10-01	Horvath Susan(V.P. of Finance & CFO)	A	$0
2023-09-12	Jacob Jeffrey E.	G	$0
2023-03-27	Schemel Donald Robert	A	$0
2023-03-27	MATHIESEN JEFFREY S	A	$0
2023-03-27	Jacob Jeffrey E.	A	$0
2023-03-27	Fratamico Arthur	A	$0
2023-03-27	Donovan Daniel	A	$0
2023-03-27	Cullen Michael T.	A	$0
2023-03-27	Horvath Susan(V.P. of Finance & CFO)	A	$0
2023-03-27	Simpson Jennifer K.(President and CEO)	A	$0
2023-01-30	Horvath Susan(V.P. of Finance & CFO)	Buy	$0
2023-01-30	Horvath Susan(V.P. of Finance & CFO)	Buy	—
2023-01-30	Simpson Jennifer K.(President and CEO)	Buy	$0
2023-01-30	Simpson Jennifer K.(President and CEO)	Buy	—
2022-10-04	Jacob Jeffrey E.	Buy	$0
2022-10-04	Jacob Jeffrey E.	Buy	—
2022-10-04	Schemel Donald Robert	Buy	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Panbela Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope